“…Sleep disorders such as sleep-disordered breathing and insomnia, as well as poor sleep quality, circadian misalignment, and short sleep duration, are implicated in increased risk for adverse outcomes. Poor sleep quality, short sleep duration, and insomnia, for instance, are associated with new and recurrent depressive episodes (Bei et al, 2010;Dorheim, Bjorvatn, & Eberhard-Gran, 2012;Goyal, Gay, & Lee, 2007;Kamysheva, Skouteris, Wertheim, Paxton, & Milgrom, 2009;Okun, Hanusa et al, 2009;Okun, Luther et al, 2013;Skouteris, Wertheim, Germano, Paxton, & Milgrom, 2009), preterm birth (Guendelman et al, 2013;Micheli et al, 2011;Okun, Schetter, & Glynn et al, 2011 (Ayrim et al, 2011;Bourjeily et al, 2010;Champagne et al, 2009;O'Brien et al, 2012;Williams et al, 2010), labor and delivery outcomes (Beebe & Lee, 2007;Evans et al, 1995;Lee & Gay, 2004), and immune/endocrine dysregulation Okun, Luther, Prather et al, 2011;Okun, Luther, Wisniewski, & Wisner, 2013); and a few examined infant outcomes (Ayrim et al, 2011;Bourjeily et al, 2010;Franklin et al, 2000;Goyal, Gay, & Lee, 2009;Nishihara & Horiuchi, 1998). Sleep-disordered breathing, which involves hypoxia and sleep disruption, is similarly associated with the adverse outcomes and predominantly associated with preeclampsia, gestational diabetes, gestational hypertension, intrauterine growth restriction, and low birth weight (Carnelio, Morton, & McIntyre, 2017).…”